Looking ahead, local therapies and biomarkers may become even more important in the management of kidney cancer.
Chad Tang, MD
Advertisement
Articles by Chad Tang, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
BCMA-Directed Bispecific Antibodies Navigating a New Era in Relapsed/Refractory Multiple Myeloma
3
Nogapendekin Alfa/BCG BLA Resubmitted for NMIBC Population
4
Considering Venlafaxine as Distress Treatment in Breast Cancer
5